Patents by Inventor Hajime Hosoi

Hajime Hosoi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHIMERIC ANTIGEN RECEPTOR GENE-MODIFIED LYMPHOCYTE HAVING CYTOCIDAL EFFECT
    Publication number: 20230295568
    Abstract: An object of the present invention is to provide a therapeutic strategy in the solid tumor area and a means useful therefor to further advance the clinical application of CAR therapy. There is prepared a gene-modified lymphocyte which expresses a chimeric antigen receptor having an EphrinB2 extracellular domain at the antigen recognition site.
    Type: Application
    Filed: February 13, 2023
    Publication date: September 21, 2023
    Applicants: Shinshu University, Kyoto Prefectural Public University Corporation
    Inventors: Hajime Hosoi, Tomoko Iehara, Shigeki Yagyu, Yozo Nakazawa
  • CHIMERIC ANTIGEN RECEPTOR GENE-MODIFIED LYMPHOCYTE HAVING CYTOCIDAL EFFECT
    Publication number: 20190343880
    Abstract: An object of the present invention is to provide a therapeutic strategy in the solid tumor area and a means useful therefor to further advance the clinical application of CAR therapy. There is prepared a gene-modified lymphocyte which expresses a chimeric antigen receptor having an EphrinB2 extracellular domain at the antigen recognition site.
    Type: Application
    Filed: December 6, 2017
    Publication date: November 14, 2019
    Applicants: Shinshu University, Kyoto Prefectural Public University Corporation
    Inventors: Hajime HOSOI, Tomoko IEHARA, Shigeki YAGYU, Yozo NAKAZAWA
  • Method for detecting rhabdomyosarcoma using sample derived from body fluid
    Patent number: 8975021
    Abstract: The present invention provides a method for detecting rhabdomyosarcoma comprising evaluating expression of at least one kind of miRNA selected from the group consisting of hsa-miR-1, hsa-miR-133a, hsa-miR-133b, and hsa-miR-206 in a sample derived from body fluid.
    Type: Grant
    Filed: April 7, 2011
    Date of Patent: March 10, 2015
    Assignees: Kyoto Prefectural Public University Corporation, LSIP, LLC
    Inventors: Hajime Hosoi, Mitsuru Miyachi
  • METHOD FOR DETECTING RHABDOMYOSARCOMA USING SAMPLE DERIVED FROM BODY FLUID
    Publication number: 20130203062
    Abstract: The present invention provides a method for detecting rhabdomyosarcoma comprising evaluating expression of at least one kind of miRNA selected from the group consisting of hsa-miR-1, hsa-miR-133a, hsa-miR-133b, and hsa-miR-206 in a sample. derived from body fluid.
    Type: Application
    Filed: April 7, 2011
    Publication date: August 8, 2013
    Applicants: LSIP, LLC, KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION
    Inventors: Hajime Hosoi, Mitsuru Miyachi